September 3, 2026 Popular diet slashes liver fat by 67% while reversing prediabetes in some people A keto diet reduced liver fat by roughly 67% and reversed prediabetes in half of participants, but the study's small sample size is a caveat.
September 2, 2026 Women who start common hormone therapy in their 50s may have 23% lower dementia risk Hormone replacement therapy started between ages 46 and 56 was tied to lower Alzheimer's and dementia risk, a major new UK Biobank study suggests.
September 2, 2026 New weight-loss compound melts fat without curbing appetite — and preserves muscle University of California, Berkeley scientists found TOFA boosted energy expenditure in obese mice without the lean muscle loss tied to semaglutide.
September 1, 2026 Teen dies from ‘brain-eating amoeba’ just days after young girl succumbs to same rare infection A North Carolina teen's first symptom was severe headaches before a brain-eating amoeba infection proved fatal, his mother shared on GoFundMe.
August 31, 2026 Popular artificial sweetener linked to potentially dangerous heart risk A new study of over 17,700 participants links higher xylitol blood levels to increased cardiovascular risk, including heart attack and stroke, over future decades.
August 28, 2026 Common vaccine linked to 24% lower dementia risk in older adults A Brown University study found Shingrix reduced dementia risk by 24% over four years, building on prior research linking the shingles vaccine to brain health.
August 27, 2026 Popular weight-loss strategy shows surprising potential for chronic pain relief A study reveals that intermittent fasting reshapes the gut microbiome to strengthen the intestinal lining and block inflammatory compounds from the brain.
August 27, 2026 FDA approves breakthrough pancreatic cancer drug Rasonque Family medicine physician Dr. Jessica Gray discusses the FDA’s approval of Rasonque, a breakthrough pancreatic cancer drug on ‘Fox & Friends.’
August 26, 2026 FDA approves once-daily pill for deadly cancer after patients' survival rates nearly double Revolution Medicines' Rasonque targets the RAS protein driving 95% of pancreatic adenocarcinoma cases, offering a critical option after chemotherapy fails.
August 26, 2026 Eating less of common ingredient early in life may slash cancer risk decades later Researchers found that early-life sugar rationing in post-war Britain correlated with lower cancer risk and slower aging roughly 50 years later.